PMID: 16612472Apr 14, 2006Paper

Effects of metformin on the glycemic control, lipid profile, and arterial blood pressure of type 2 diabetic patients with metabolic syndrome already on insulin

Brazilian Journal of Medical and Biological Research = Revista Brasileira De Pesquisas Médicas E Biológicas
C A Mourão-JúniorS A Dib

Abstract

Fifty-seven type 2 diabetic patients with metabolic syndrome and on insulin were assessed by a paired analysis before and 6 months after addition of metformin as combination therapy to evaluate the impact of the association on glycemic control, blood pressure, and lipid profile. This was a historical cohort study in which the files of type 2 diabetic patients with metabolic syndrome on insulin were reviewed. The body mass index (BMI), waist circumference, lipid profile, A1C level, fasting blood glucose level, daily dose of NPH insulin, systolic blood pressure, and diastolic blood pressure were assessed in each patient before the start of metformin and 6 months after the initiation of combination therapy. Glycemic control significantly improved (P < 0.001) after the addition of metformin (1404.4 +/- 565.5 mg/day), with 14% of the 57 patients reaching A1C levels up to 7%, and 53% reaching values up to 8%. There was a statistically significant reduction (P < 0.05) of total cholesterol (229.0 +/- 29.5 to 214.2 +/- 25.0 mg/dL), BMI (30.7 +/- 5.4 to 29.0 +/- 4.0 kg/m2), waist circumference (124.6 +/- 11.7 to 117.3 +/- 9.3 cm), and daily necessity of insulin. The reduction of total cholesterol occurred independently of the reductions ...Continue Reading

Associated Clinical Trials

References

Oct 1, 1988·Diabetic Medicine : a Journal of the British Diabetic Association·S G RainsR S Elkeles
May 11, 1995·The New England Journal of Medicine·A S KrolewskiJ H Warram
May 23, 2001·JAMA : the Journal of the American Medical Association·UNKNOWN Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults
Jan 26, 2002·Journal of Clinical Pharmacology·Linda A JaberRichard R Slaughter
Jul 3, 2002·Annals of Internal Medicine·Dmitri KirpichnikovJames R Sowers
Nov 28, 2002·Diabetes Care·Michiel G WulffeléCoen D A Stehouwer
May 8, 2003·JAMA : the Journal of the American Medical Association·Dawn E DeWitt, David C Dugdale
Oct 28, 2003·Diabetes Care·Carlos LorenzoUNKNOWN San Antonio Heart Study
Nov 2, 2004·Brazilian Journal of Medical and Biological Research = Revista Brasileira De Pesquisas Médicas E Biológicas·K J MeenakumariL K Pandey
Feb 3, 2005·Obesity Research·Carla J H van der KallenTjerk W A de Bruin
Aug 17, 2005·The Journal of Clinical Hypertension·Camila ManriqueJames R Sowers

❮ Previous
Next ❯

Related Concepts

Related Feeds

Biomarkers for Type 2 Diabetes

Biomarkers can help understand chronic diseases and assist in risk prediction for prevention and early detection of diseases. Here is the latest research on biomarkers in type 2 diabetes, a disease in which the body is unable to produce or properly use insulin.